Altered Cerebral {gamma}-Aminobutyric Acid Type A-Benzodiazepine Receptor Binding in Panic Disorder Determined by [11C]Flumazenil Positron Emission Tomography
Hasler et al.
Arch Gen Psychiatry 2008;65:1166-1175.
ABSTRACT
| FULL TEXT
Reduced {gamma}-Aminobutyric AcidA-Benzodiazepine Binding Sites in Insular Cortex of Individuals With Panic Disorder
Cameron et al.
Arch Gen Psychiatry 2007;64:793-800.
ABSTRACT
| FULL TEXT
A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers
Bailey et al.
J Psychopharmacol 2007;21:42-49.
ABSTRACT
Individual differences in aggressive responding to intravenous flumazenil administration in adult male parolees
Tcheremissine et al.
J Psychopharmacol 2005;19:640-646.
ABSTRACT
Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine
Bell et al.
J Psychopharmacol 2002;16:5-14.
ABSTRACT
New insights into the role of the GABAA--benzodiazepine receptor in psychiatric disorder
NUTT and MALIZIA
Br. J. Psychiatry 2001;179:390-396.
ABSTRACT
| FULL TEXT
Panic Disorder-A Malfunction of Multiple Transmitter Control Systems within the Midbrain Periaqueductal Gray Matter?
Lovick
Neuroscientist 2000;6:48-59.
ABSTRACT
Flumazenil Discrimination by Humans under a Two-Response and a Novel-Response Procedure
Smith and Bickel
J. Pharmacol. Exp. Ther. 1999;291:1257-1268.
ABSTRACT
| FULL TEXT
What do brain imaging studies tell us about anxiety disorders?
Malizia
J Psychopharmacol 1999;13:372-378.
ABSTRACT
Decreased Brain GABAA-Benzodiazepine Receptor Binding in Panic Disorder: Preliminary Results From a Quantitative PET Study
Malizia et al.
Arch Gen Psychiatry 1998;55:715-720.
ABSTRACT
| FULL TEXT
Catecholamines and Pathogenesis in Panic Disorder
Heninger
Arch Gen Psychiatry 1998;55:522-523.
FULL TEXT
Flumazenil-precipitated panic and dysphoria in patients dependent on benzodiazepines: a possible aid to abstinence
Harrison-Read et al.
J Psychopharmacol 1996;10:89-97.
ABSTRACT
Flumazenil-precipitated panic and dysphoria in patients dependent on benzodiazepines: a possible aid to abstinence--authors' response
Harrison-Read et al.
J Psychopharmacol 1996;10:99-100.
Lorazepam 0.25 mg twice a day improves aspects of psychometric performance in healthy volunteers
Bourin et al.
J Psychopharmacol 1995;9:251-257.
ABSTRACT
Benzodiazepine receptors and positron emission tomography: ten years of experience. A new beginning?
Malizia and Richardson
J Psychopharmacol 1995;9:355-368.
Paradoxical acute anxiety exacerbation with alpidem in a panic disorder patient
Bisserbe and Boulenger
J Psychopharmacol 1994;8:189-190.
False Suffocation Alarms, Spontaneous Panics, and Related Conditions: An Integrative Hypothesis
Klein
Arch Gen Psychiatry 1993;50:306-317.
ABSTRACT
Chronic Use of Alcohol and/or Benzodiazepines May Account for Evidence of Altered Benzodiazepine Receptor Sensitivity in Panic Disorder
Stewart et al.
Arch Gen Psychiatry 1992;49:329-330.
ABSTRACT
The cholecystokinin hypothesis of panic and anxiety disorders: a review
Bradwejn et al.
J Psychopharmacol 1992;6:345-351.
ABSTRACT
A pilot study of the effects of flumazenil on symptoms persisting after benzodiazepine withdrawal
Lader and Morton
J Psychopharmacol 1992;6:357-363.
ABSTRACT
Imipramine in panic disorder. 2. Effects on {alpha}2-adrenoceptor function
Nutt and Glue
J Psychopharmacol 1991;5:135-141.
ABSTRACT
Flumazenil-precipitated withdrawal symptoms in chronic users of therapeutic doses of diazepam
Bernik et al.
J Psychopharmacol 1991;5:215-219.
ABSTRACT
Integrating psychology and pharmacology in the management of anxiety: a reply to 'Psychology and pharmacology in the treatment of anxiety disorders'
Wardle
J Psychopharmacol 1991;5:293-295.
Merck, Sharp & Dohme Prize for Young Psychopharmacologists: The pharmacology of saccadic eye movements
Glue
J Psychopharmacol 1991;5:377-387.
ABSTRACT
